Northwest Biotherapeutics signs Saudi MOU with SPIMACO for DCVax-L

The non-binding agreement outlines potential approval, commercialization, supply and technology transfer for glioblastoma treatment in Saudi Arabia, with scope to expand to other indications and GCC markets.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.